Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
ISTH Academy Webinar: Cancer Detection in VTE Patients
Tell a Friend About This EventTell a Friend
ISTH Academy Webinar: Cancer Detection in VTE Patients

When: May 24, 2017
15:00 UTC/GMT

« Go to Upcoming Event List  

May 24, 2017 15:00 - 16:00 UTC

ISTH Core Curriculum 10.2 – Hypercoaguable States, 11.3, 11.5, 11.8 –Clinical Aspects of VTE, 13.1– Antithrombotic Agents


Marc Carrier "What is the role of cancer screening for patients with VTE?"

Unprovoked venous thromboembolism can be the first manifestation of an undiagnosed cancer. Dr. Carrier will review the incidence of occult cancer detection in this patient population. He will also discuss the optimal management plan and review the evidence supporting the different occult cancer screening strategies.

Aurélien Delluc "Management of incidentally-found VTE in cancer patients"

Incidentally discovered pulmonary embolism is more and more frequent. Dr. Delluc will review epidemiological data in this patient population and he will discuss the optimal management plan, especially in cancer patients.   

Moderator: Pedro Las Casas


Marc Carrier

Dr. Marc Carrier, M.D., FRCP(C), MSc. is an Associate Professor in the Faculty of Medicine, Departments of Medicine and Epidemiology at the University of Ottawa and a Scientist in the Clinical Epidemiology Program of the Ottawa Hospital Research Institute. Dr. Carrier is holding a Tier 2 Research Chair in Venous Thromboembolism and Cancer from the University of Ottawa and New Investigator Award from the Heart and Stroke Foundation of Canada.

Aurélien Delluc

Dr. Aurélien Delluc, M.D, Ph.D., is a Full Professor of internal medicine at the Western Brittany University, France, a physician in the Department of Internal Medicine and Chest Diseases at Brest University Hospital and a Senior Scientist in the “Groupe d’étude de la thrombose de Bretagne occidentale” Western Brittany Study Group on Thrombosis, EA3878, Ministère de l’Enseignement Supérieur et de la Recherche, France. He was born and trained in France.

His primary research interest is the evaluation of venous thromboembolism risk (VTE) including the overall epidemiology of VTE, links between atherothrombosis and VTE, cancer-associated thrombosis, and VTE risk associated with hospitalization. He is a member of the International Society on Thrombosis and Haemostasis, and a regular reviewer for thrombosis journals. 

Pedro Las Casas

Pedro Las Casas is a medical doctor and Hematology and Hemotherapy fellow at Universidade Federal de Minas Gerais, in Belo Horizonte, Brazil. He has created a network in Latin America among early career professionals to improve the exchange of knowledge in several ways. His areas of research interest include thromboprophylaxis in oncology patients and the incidence of venous thromboembolism, and the role of immune tolerance induction in hemophilia patients. He has been a member of the ISTH Early Career Task Force since the ISTH Congress in Toronto, 2015, and is proud to be part of the Task Force. He hopes to contribute by reaching and involving many other early career professionals in the field of thrombosis and hemostasis, particularly in Latin America, with the ISTH and its activities.


Supported by an unrestricted educational grant from: 

Membership Management Software Powered by YourMembership  ::  Legal